[Post-Show Report] Asia's Largest Bio Event, "BIO tech 2012 in Japan"

TOKYO--(BUSINESS WIRE)-- Asia's largest bio event, BIO tech 2012 in Japan (Int'l Bio Technology Exhibition & Conference) was held from April 25 to 27 in Tokyo.

Co-held with Conference consisting of 261 sessions, it gathered 498 exhibitors and 15,814 visitors from around the world. Renewed as "BIO tech in Japan" from "INT'L BIO FORUM & BIO EXPO JAPAN", there were increased number of appreciative comments from both exhibitors and visitors.

The followings are the highlights from BIO tech 2012, which concluded in huge success.

1) Partnering – Partnering deals and new business were generated here.

The 2012 show was a commemorable one, in the sense that BIO tech has further strengthened itself as a full-scale partnering event. Through the online "Bio Partnering System" and on-site meetings, many partnering opportunities were generated among exhibitors, academics and visitors including Pharma Company Sponsors.

Above all other partnering events worldwide, BIO tech 2012 had its strength in gathering a large number of academics rich in bio/pharma-related seeds, due to the presence of the "Academic Forum". Academic Forum 2012 proved itself as a platform for "business-academia collaboration", gathering 198 presenters (largest-ever) from universities/institutes such as RIKEN, The University of Tokyo, Kyoto University and many others.

Among presentations on various themes, the followings were the Top 5 popular sessions.

No.1) Humanized mouse for translating research findings into medicine

No.2) High sensitive diagnostic system of viruses using sugar-chain and nanobiotechnology

No.3) Development of evaluation technology of human stem cells and our approach for the industrial usage

No.4) Cardiomyoblast-like cells derived from human adipose tissue improve chronic heart failure

No.5) Development of New Saliva Test

Being the best gateway to the Japanese academia as well as biotech companies from around the world, BIO tech 2012 attracted a large number of professionals from pharmaceutical companies from home and abroad.

2) Exhibition – Exhibitors satisfaction was greatly increased.

The renewal was favorably received by exhibitors as well, who have achieved highly successful results. The followings are some of the exhibitors' comments.

SCRUM
We exhibit at BIO tech every year, since it has always led to successful results. Especially this year, we expect even bigger achievement, with 200 meetings on-site, 5 orders and sales for approx. USD 500,000.

OZEKI
BIO tech 2012 was the best ever among all exhibitions we have participated in, in terms of both the number of visitors to our booth and cost-effectiveness. 　　　　　 　 　　　　　　　　　　　　　　　　　

ESCO MICRO
Exhibiting at BIO tech 2012 proved highly successful. Targeting mainly the Asian market, we choose BIO tech as our only exhibition to participate annually.

The 2013 show will further expand its scale and become more international. >> Exhibiting Info Request

3) Conference – Asia's leading conference with 4,942 attendees.

One of the most popular sessions was the Keynote Session, addressed by Vice President of Merck's vaccines discovery, Prof. Kodama from The University of Tokyo; pioneer of IT based drug development, and the project leader of Novo Nordisk's biopharmaceutical business. Covering the current hot topics, it served as an essential opportunity to forecast the prospects of the bio/pharma industry. >> Full Program

As a comprehensive bio event consisting of Partnering, Exhibition & Conference, BIO tech 2012 showed its presence in the Asian bio industry.

"BIO tech 2013 in Japan" will take place with larger scale on May 8-10, 2013 at Tokyo Big Sight.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50291789&lang=en